The Swiss HLG is proud to host the opening panel at Swiss Biotech Day!
The panel will start at 14.45 on Monday 24th April and has the title How can Swiss biotechs remain competitive in a challenging environment for early stage financing and partnering?
The Swiss Venture Capital Report 2023 revealed that investment in Swiss biotech fell by nearly half in 2022. The panel will discuss this dramatic fall in the current industry context and consider how the vibrant Swiss innovation ecosystem can best compete on the global stage.
We are delighted to have perspectives from VC Veronica Gambillara Fonck from Pureos Bioventures, Pharma Michael R Huebner from Johnson & Johnson, Biotech Dr. Alexander Breidenbach from ACM Biosciences AG and of course the indispensable Venturelab with Jordi Montserrat.
Please join us at Swiss Biotech Day!
